Cargando…
Therapeutic regulation of complement in patients with renal disease – where is the promise?
Numerous renal diseases are characterized by complement activation within the kidney, and several lines of evidence implicate complement activation as an important part of the pathogenesis of these diseases. Investigators have long anticipated that complement inhibitors would be important and effect...
Autor principal: | Thurman, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407337/ https://www.ncbi.nlm.nih.gov/pubmed/22551888 http://dx.doi.org/10.5414/CN107220 |
Ejemplares similares
-
Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019) -
The Challenges and Promise of Complement Therapeutics for Ocular Diseases
por: Park, Dong Ho, et al.
Publicado: (2019) -
Complement and Cancer—A Dysfunctional Relationship?
por: Thurman, Joshua M., et al.
Publicado: (2020) -
The complement system in pediatric acute kidney injury
por: Stenson, Erin K., et al.
Publicado: (2022) -
Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams
por: Pan, Darren, et al.
Publicado: (2022)